Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Above .055 today!!
Bullish wedge breakout to hit imo!
Very positive tweets. It’s about to go off!
Monster close in the making!
Loading zone for next leg up!
Tweets out! Attorney letter in! Pink very soon....
Mexico weed is thee place to be right now! .05 min imo...
Money Monday! March 15th....
Holding till .05!
“I feel very confident that Inovio’s vaccines, be it our original vaccine or our potential pan-variant vaccine, is going to have a huge impact globally,” Dr. Broderick said.
Doubled up!!
It’s about to run hard!
It’s almost time Miami! Pull those covers up....
This xxxx is getting real. Ino has vaccine. Multiple catalysts are going to send this into triple digits soon imo.
https://www.usnews.com/news/world/articles/2021-02-15/who-sounds-regional-warning-over-ebola-outbreaks-in-congo-guinea
$35 price target short term....
Published today in nature!
https://www.nature.com/articles/s41541-021-00290-y
Cellectra device and t-cells. Wonder why no other pharma is talking about it. Cause their vaccine doesn’t address it.
Citron buster tomorrow!
But it does allow us to expand and grow into new businesses, too, including into big categories like sleep, infertility, diabetes and other chronic conditions.
TC: What about acquisitions?
AD: We’ll keep an eye open for strategic opportunities and consolidation opportunities. More than a dozen businesses a month come to us to be consolidated into the brand, but generally speaking, we’ve had the belief that so much is in front of us that we don’t want to be distracted.
As of last quarter, the business was growing 90% year-over-year, with 76% gross margins and greater cash efficiency, and that’s because as we provide more offerings, there is more cross-purchasing. Also, word of mouth is becoming more of a dynamic, with more than 50% of the traffic to the site free at this point because we have built a brand with a young demographic.
TC: You’re a Bay Area-based company selling to a mostly U.S. audience. How are you thinking about expanding that footprint geographically?
AD: We do have a small operation selling in the U.K.; we’re getting our feet wet in that market and building out a team and infrastructure and fulfillment. If you look at the regulatory landscape, there’s a huge amount of room [to grow] in Europe, Australia, Canada, the Middle East and Asia, and so in that order, we’ll start to [move into those markets].
On the contrary, Dudum says that while Hims might have once imagined a traditional IPO, it decided to go the special purpose acquisition company (SPAC) route because of their pricing mechanisms and because it was approached by a SPAC led by renowned money manager Howard Marks, the founder of the global alternative investment firm Oaktree Capital Management. (“We fell in love with the Oaktree team and the capital market experience and deep resources they have.”)
Big news for launch tomorrow!
https://www.businessinsider.com/ceo-of-hims-reveals-secret-trip-to-asia-2021-1
Welcome inovians! Going to be a great week. Just got back in. I was there from 5-30. Now ready for 10-60! mRNA out, dna in... good to see Miami is still here. Short squeeze will be epic.
25 pre merger than big pop!
Pop to $25 upcoming
Loading up here!
Launching crypto exchange in 1st q. Think 7-10 today....
Dna tech confirmed here today! First of many positive game changing steps...
Grabbing these 12.40ssss
I’m guessing because they have sh$$ton of vaccines to distribute!
Kaneka manufacturing deal! Next up ino 4800...
$183.33 mark it!
Going to triple from here!
No dilution per Kim.
Maybe, but not for long!